Sökresultat

Gunilla Westergren-Thorsson, Professor of Lung Biology at Lund University, has been awarded the European Respiratory Society (ERS) Lifetime Achievement Award in Basic and Translational Science 2025. The European Respiratory Society is a leading international organisation with more than 35,000 members from over 160 countries, working to improve lung health through research, education, and clinical

https://www.medicine.lu.se/article/lifetime-achievement-award-gunilla-westergren-thorsson - 2025-11-23

From a rejected article to world-leading Alzheimer’s research. Kaj Blennow has made it possible to detect Alzheimer’s disease up to 20 years before symptoms appear – an achievement that has not only transformed research but also laid the foundation for new therapies. He has now been awarded the Eric K. Fernström Nordic Prize for his groundbreaking research. Professor Kaj Blennow also enjoys gettin

https://www.medicine.lu.se/article/lund-world-stage-meet-fernstrom-prize-winner-kaj-blennow - 2025-11-23

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body’s immune system. By developing an antibody that blocks the mechanism, the researchers could restore the immune system’s ability to kill the cancer cells in laboratory trials and in mice. The discovery is published in Nature Cancer. In brief:Facts about the study: peer-r

https://www.medicine.lu.se/article/new-mechanism-revealed-how-leukemia-cells-trick-immune-system - 2025-11-23

Congratulations to Hanna Thorsson, whose thesis has been awarded the title of Best Hematology Thesis of 2025 by the Swedish Society of Hematology. In May 2025, Hanna Thorsson defended her doctoral thesis, “Single-cell Sequencing of Acute Leukemia” at Lund University. In October, she was awarded “Best Hematology Thesis of the Year” (Årets bästa avhandling i hematologi) by Svensk förening för hemato

https://www.medicine.lu.se/article/best-hematology-thesis-year - 2025-11-23

During the Covid-19 pandemic, there was an unexpected increase in the number of cases of type 1 diabetes in Sweden, particularly among children under five and young adult men. The infection accelerated the onset of diabetes among children between the ages of five and nine. The researchers looked at data from a 17-year period on the incidence of type 1 diabetes among all people under the age of 30

https://www.medicine.lu.se/article/type-1-diabetes-increased-among-young-people-during-pandemic - 2025-11-23

Researchers at Lund University have identified a previously unknown precursor stage of leukemia. The discovery may help explain why an especially aggressive form of blood cancer initiates already during fetal life. When we think of cancer, we usually imagine a disease that develops over many years in adults. But for one particular group of leukemia – acute lymphoblastic leukemia (ALL) – it is quit

https://www.medicine.lu.se/article/study-offers-clues-why-leukemia-develops-infants - 2025-11-23

Pregnancies do not weaken a woman’s skeleton. Breastfeeding, however, can reduce bone density considerably. These are findings from a research report produced at Lund University in Sweden. But breastfeeding women need not worry. “There is a dip, but the body is absolutely fantastic at making up the loss,” says Kristina Åkesson, professor of orthopedics. Breastfeeding and pregnancy both require lar

https://www.medicine.lu.se/article/new-findings-how-breastfeeding-affects-skeleton-could-boost-development-drugs-against-osteoporosis - 2025-11-23

Martin L. Olsson, professor of Transfusion Medicine at Lund University, has received the 2025 President’s Award from the Association for the Advancement of Blood and Biotherapies (AABB). The citation reads: “For important, pioneering research and leadership that has advanced the field of transfusion medicine, transplantation and biotherapies, and has improved donor and patient safety.”“The award h

https://www.medicine.lu.se/article/martin-l-olsson-receives-presidents-award - 2025-11-23

During two well-attended days, researchers, healthcare professionals and interested members of the public gathered in Malmö and Lund to take part in the latest research in the field. Research Day 2025 with the theme "Children's minds taken seriously – About Children's and Young People's Mental Health", offered a wide-ranging program of lectures, discussions and films. Moderator Lisa Kirsebom led t

https://www.medicine.lu.se/article/young-peoples-mental-health-focus-research-day - 2025-11-23

Inflammation researcher Ben King studies the function of two different proteins in connection with diabetes. In the future, such knowledge may be important for the development of new treatments for people with diabetes. Ben King is this year’s recipient of the Medeon Award for his innovative research. “I was very surprised and feel very honored to receive the award. In my role, I do a lot of exper

https://www.medicine.lu.se/article/award-protein-research-may-lead-new-treatments-diabetes - 2025-11-23

How can a tiny genetic change alter the body´s sugar balance? At Lund University, researchers have used stem cells to create two versions of the same cell – one carrying the genetic variant and one without – to see how melatonin affects insulin-producing cells and contributes to development of type 2 diabetes. Study summarySkin cells from a person carrying a risk gene for type 2 diabetes were “rep

https://www.medicine.lu.se/article/stem-cell-technology-reveals-new-insights-melatonin-and-diabetes - 2025-11-23

Jonna Bornemark, professor of philosophy at Södertörn University, Sara Heyman, foreign correspondent at Ekot, and Roger Barker, professor of clinical neuroscience at the University of Cambridge, have been appointed honorary doctors for 2026 at the Faculty of Medicine. A philosopher who deepens and renews the public conversation on ethics, judgement, and views of humanity within healthcare and medi

https://www.medicine.lu.se/article/philosopher-journalist-and-leading-neuroscientist-appointed-new-honorary-doctors - 2025-11-23

Diabetes researchers at Lund University have previously shown that people with diabetes can be stratified into five subgroups with differing disease progression. A new study by the same researchers provides increased evidence for the clinical relevance of the classification system. The researchers also present new findings of significant differences between subgroups in the development of complica

https://www.medicine.lu.se/article/new-research-classification-diabetes-identifies-high-risk-group - 2025-11-23

(DIABETES) After more than a decade of stagnation, there is a major surge in kidney research effort. New drugs and biomarkers make it possible to detect and slow the progression of the disease earlier – something that long seemed unattainable. This will impact people with diabetes, for whom kidney damage is a serious long-term complication. “We are entering a new era. What is happening now is simi

https://www.medicine.lu.se/article/hope-kidney-care - 2025-11-23

An international team of researchers has investigated whether oral insulin can prevent early signs of type 1 diabetes and clinical diagnosis in children with an increased risk of developing the disease. Although treatment with oral insulin could not prevent development of diabetes-related autoantibodies, oral insulin delayed the rate of disease progression in children who developed such autoantibo

https://www.medicine.lu.se/article/oral-insulin-delayed-onset-type-1-diabetes-some-children-increased-risk-disease - 2025-11-23

Lund University has climbed to first place in the world in the QS World University Rankings: Sustainability 2026. The ranking includes around 2,000 higher education institutions from about 100 countries and measures how universities contribute to a sustainable future – through research, education, and the way they operate as organisations. “Humble, proud, and inspired to continue moving forward –

https://www.medicine.lu.se/article/lund-university-ranked-best-world-sustainability - 2025-11-23

Christopher Douse, Associate Professor at Lund University’s Faculty of Medicine and group leader at the Lund Stem Cell Center, has been awarded a Consolidator Grant from the Swedish Society for Medical Research (SSMF). The five-year, SEK 11 million award will support his team’s research into how repetitive DNA sequences linked to neurological diseases are controlled in the development of the human

https://www.medicine.lu.se/article/decoding-repetitive-genome-christopher-douse-awarded-consolidator-grant-ssmf - 2025-11-23

Borders don’t just divide nations — they define our bodies too. At the skin and in the gut, our barrier organs form the frontline of defense against infection. Here, diverse communities of friendly microbes, the microbiota, help maintain health and keep these borders strong, backed up by an immune system ready to deploy antibodies against any intruder. Protecting these barrier organs is central to

https://www.medicine.lu.se/article/inta-gribonika-awarded-ssmf-starting-grant-research-skin-humoral-immunity - 2025-11-23

The most common form of childhood cancer is acute lymphoblastic leukaemia (ALL). Researchers at Lund University in Sweden, in cooperation with Karolinska Institutet, SciLifeLab and the University of Cambridge, have now carried out the most extensive analysis to date of ALL at the protein level, by studying the activity in over 8 000 genes and proteins. The results show aberrant folding in the DNA

https://www.medicine.lu.se/article/first-major-study-proteins-patients-acute-lymphoblastic-leukaemia - 2025-11-23

Feng Zhang, professor at the Broad Institute of MIT and Harvard visited Lund University at the beginning of March to deliver the annual honorary lecture organised by the Royal Physiographic and Mendelian Societies in Lund. First published: 2019-05-26Listen to the interview and hear more about why Feng Zhang wants to introduce a moratorium on genetically-modified babies and where Malin Parmar hopes

https://www.medicine.lu.se/article/honorary-lecturer-feng-zhang-crispr-research-treasure-hunt-nature - 2025-11-23